维普期刊资源整合服务平台（V6.5）

4812篇 您的检索式：期刊名="Oncologist"

选中清除导出查看参考文献查看引证文献引用追踪共241页首页上一页第1页下一页末页 /241 跳转

	题名	作者	年代	出处	被引量
1	Behavoral risk factors in breast cancer:can risk be modified ? 显示文摘	Mctiernan A	2003	Oncologist2003，8，4：	2
2	Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer显示文摘	Socinski MA	1999	Oncologist1999，4，5：	2
3	The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated with Prognosis in Hodgkin’s Lymphoma: Correlation with Tumor-Associated Macrophages显示文摘	Young Wha Koh Hyo Jeong Kang Chansik Park Dok Hyun Yoon Shin Kim Cheolwon Suh Heounjeong Go Ji Eun Kim Chul-Woo Kim Jooryung Huh	2012	The Oncologist2012，，6：	2
4	FDA drug approval summaries:Pemetrexed(alimta)显示文摘	Hazarika M White R M Johnson J R	2004	Oncologist2004，9，5：	1
5	FDA drug approval summary: erlotinib (tarveva) tablets显示文摘	COHEN M H JOHNSON J R CHEN Y F	2005	Oncologist2005，10，7：	1
6	Surgical management of spinal metastases显示文摘	Klimo P Jr Schmidt MH	2004	Oncologist2004，9，：	1
7	Adenoviral genetherapy 显示文摘	Vorburger S A Hunt K K	2002	Oncologist2002，7，1：	1
8	Targeting vascular endothelial growth factor blockade:ascites and pleural effusion formation显示文摘	Verheul HM Hoekmann K Jorna AS	2000	Oncologist2000，5，1：	1
9	Prognostic value of vascular endothelial growth factor in breast cancer显示文摘	Gasparini G	2000	Oncologist2000，5，1：	1
10	Diagnostic value of CYFRA21 - 1 ,CEA,CA19 -9 ,CA15 - 3 and CA125 assays in pleural effusions:analysis of 116 cases and review of the literature 显示文摘	ShitritD Zingcrman B ShitritAB	2005	Oncologist2005，10，7：	1
11	The NCCN clinical practice guidelines on venous thromboembolic disease:strategies for improving VTE prophylaxis in hospitalized cancer patients显示文摘	Khorana A A	2007	Oncologist2007，12，11：	1
12	VEGF receptor signaling in tumor angiogenesis显示文摘	McMahon G	2000	Oncologist2000，5，1：	1
13	Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status显示文摘	Treat J Huang C H Lane S R	2004	Oncologist2004，9，2：	1
14	A phase Ⅲ study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer显示文摘	Gridelli Elvis	2001	Oncologist2001，，：	1
15	The roles of sargramostim (rhGM-CSF) as immunotherapy显示文摘	Waller EK	2007	Oncologist2007，12，2：	1
16	Recent developments in acute myelogenous leukemia therapy 显示文摘	King M E Rowe J M	2007	Oncologist2007，12，2：	1
17	BRCA1, a potential predictive biomarker in the treatment of breast cancer 显示文摘	James CR Quinn JE Mullan PB	2007	Oncologist2007，12，2：	1
18	Bevacizumab in the treatment of breast cancer: rationale and current data 显示文摘	Rugo H S	2004	Oncologist2004，9，1：	1
19	Preclinical pharmacology of the taxanes:implications of the differences显示文摘	Gligorov J Lotz JP	2004	Oncologist2004，9，2：	1
20	Why the epidermal growth factor receptor?显示文摘	Baselga J	2002	Oncologist2002，7，4：	1

返回顶部每页显示：

共241页首页上一页第1页下一页末页 /241 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示